Hyloris Pharmaceuticals
Li├¿ge · Founded 2013
About Hyloris Pharmaceuticals
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris Pharmaceuticals develop innovative proprietary products that offer significant advantages compared to currently available alternatives.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $34.1M
- Funding stage: IPO
- Last round: Grant (Jun 2023)
- Ticker: ebr:HYL
- Website: hyloris.com
- Phone: +32 (0)4 346 02 07
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hyloris-pharmaceuticals-46574 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.